MHR
TAK icon

Matthew Hamilton Rosenberg’s Takeda Pharmaceutical TAK Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.6K Hold
1,723
– – 0.01% 510
2026
Q1 		$31.9K Hold
1,723
– – 0.01% 484
2025
Q4 		$26.9K Hold
1,723
– – 0.01% 503
2025
Q3 		$25.2K Sell
1,723
-381
-18% -$5.66K 0.01% 508
2025
Q2 		$32.5K Hold
2,104
– – 0.01% 499
2025
Q1 		$31.3K Hold
2,104
– – 0.01% 487
2024
Q4 		$27.9K Hold
2,104
– – 0.01% 494
2024
Q3 		$29.9K Buy
2,104
+543
+35% +$7.7K 0.01% 503
2024
Q2 		$20.3K Sell
1,561
-1,086
-41% -$14.4K 0.01% 529
2024
Q1 		$36.2K Hold
2,647
– – 0.01% 470
2023
Q4 		$37.8K Sell
2,647
-729
-22% -$10.3K 0.01% 465
2023
Q3 		$52.2K Buy
3,376
+337
+11% +$5.22K 0.02% 410
2023
Q2 		$47.7K Buy
3,039
+321
+12% +$5.26K 0.02% 437
2023
Q1 		$44.8K Hold
2,718
– – 0.01% 484
2022
Q4 		$42.4K Buy
2,718
+11
+0.4% +$154 0.01% 500
2022
Q3 		$35K Buy
2,707
+13
+0.5% +$181 0.01% 519
2022
Q2 		$38K Hold
2,694
– – 0.01% 517
2022
Q1 		$39K Hold
2,694
– – 0.01% 491
2021
Q4 		$37K Sell
2,694
-5,179
-66% -$72.6K 0.01% 463
2021
Q3 		$129K Buy
7,873
+462
+6% +$7.76K 0.05% 246
2021
Q2 		$125K Buy
7,411
+477
+7% +$8.12K 0.07% 221
2021
Q1 		$127K Buy
6,934
+586
+9% +$10.5K 0.07% 214
2020
Q4 		$115K Sell
6,348
-2,360
-27% -$41.4K 0.07% 210
2020
Q3 		$155K Buy
8,708
+10
+0.1% +$182 0.11% 115
2020
Q2 		$156K Buy
8,698
+3,155
+57% +$56.6K 0.12% 109
2020
Q1 		$85K Buy
+5,543
New +$100K 0.08% 158

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Matthew Hamilton Rosenberg's TAK Position: Q2 2026 in Review

Matthew Hamilton Rosenberg held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 1,723 shares worth $27.6K. The position accounts for 0.01% of the portfolio, ranked #510.

Matthew Hamilton Rosenberg first reported a position in TAK in Q1 2020 and has held it in 26 quarters since. The position peaked at $156K in Q2 2020. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Matthew Hamilton Rosenberg held 1,723 shares of Takeda Pharmaceutical worth $27.6K as of Q2 2026.
  • Matthew Hamilton Rosenberg left its Takeda Pharmaceutical share count unchanged in Q2 2026.
  • Takeda Pharmaceutical made up 0.01% of Matthew Hamilton Rosenberg's portfolio in Q2 2026, its #510 holding.
  • Matthew Hamilton Rosenberg first reported a position in Takeda Pharmaceutical in Q1 2020 and has held it in 26 quarters since.
  • Matthew Hamilton Rosenberg's Takeda Pharmaceutical position peaked at $156K in Q2 2020.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q2 2026, filed 17 Jul 2026.